Recent approval under new international Project Orbis.
Chronic Lymphocytic Leukemia
CD20-directed antibody indicated for several cancers and other conditions.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.